472 related articles for article (PubMed ID: 29663816)
1. Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.
Cehlar O; Skrabana R; Revajova V; Novak M
Bratisl Lek Listy; 2018; 119(4):201-204. PubMed ID: 29663816
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta peptide immunotherapy in Alzheimer disease.
Delrieu J; Ousset PJ; Voisin T; Vellas B
Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy for Alzheimer's disease].
Falkentoft AC; Hasselbalch SG
Ugeskr Laeger; 2016 Jan; 178(3):V07150588. PubMed ID: 26815584
[TBL] [Abstract][Full Text] [Related]
4. Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.
Rygiel K
Indian J Pharmacol; 2016; 48(6):629-636. PubMed ID: 28066098
[TBL] [Abstract][Full Text] [Related]
5. Passive Aβ Immunotherapy: Current Achievements and Future Perspectives.
Schilling S; Rahfeld JU; Lues I; Lemere CA
Molecules; 2018 May; 23(5):. PubMed ID: 29751505
[TBL] [Abstract][Full Text] [Related]
6. Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.
van Dyck CH
Biol Psychiatry; 2018 Feb; 83(4):311-319. PubMed ID: 28967385
[TBL] [Abstract][Full Text] [Related]
7. Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?
Panza F; Lozupone M; Dibello V; Greco A; Daniele A; Seripa D; Logroscino G; Imbimbo BP
Immunotherapy; 2019 Jan; 11(1):3-6. PubMed ID: 30702009
[No Abstract] [Full Text] [Related]
8. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
9. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
Panza F; Logroscino G; Imbimbo BP; Solfrizzi V
Curr Opin Psychiatry; 2014 Mar; 27(2):128-37. PubMed ID: 24445401
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
11. Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease.
Murakami K
Biosci Biotechnol Biochem; 2014; 78(8):1293-305. PubMed ID: 25130729
[TBL] [Abstract][Full Text] [Related]
12. Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment.
Montoliu-Gaya L; Villegas S
Expert Rev Mol Med; 2016 Jun; 18():e13. PubMed ID: 27357999
[TBL] [Abstract][Full Text] [Related]
13. SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA).
Pradier L; Blanchard-Brégeon V; Bohme A; Debeir T; Menager J; Benoit P; Barneoud P; Taupin V; Bertrand P; Dugay P; Cameron B; Shi Y; Naimi S; Duchesne M; Gagnaire M; Weeden T; Travaline T; Reczek D; Khiroug L; Slaoui M; Brunel P; Fukuyama H; Ravetch J; Canton T; Cohen C
Alzheimers Res Ther; 2018 Nov; 10(1):117. PubMed ID: 30486882
[TBL] [Abstract][Full Text] [Related]
14. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
[TBL] [Abstract][Full Text] [Related]
15. Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy.
Nitsch RM; Hock C
Neurotherapeutics; 2008 Jul; 5(3):415-20. PubMed ID: 18625453
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?
Panza F; Solfrizzi V; Imbimbo BP; Logroscino G
Expert Opin Biol Ther; 2014 Oct; 14(10):1465-76. PubMed ID: 24981190
[TBL] [Abstract][Full Text] [Related]
17. Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.
Liu J; Yang B; Ke J; Li W; Suen WC
Drugs Aging; 2016 Oct; 33(10):685-697. PubMed ID: 27699633
[TBL] [Abstract][Full Text] [Related]
18. Antibody drugs for Alzheimer's show glimmers of promise.
Reardon S
Nature; 2015 Jul; 523(7562):509-10. PubMed ID: 26223602
[No Abstract] [Full Text] [Related]
19. Molecular basis for passive immunotherapy of Alzheimer's disease.
Gardberg AS; Dice LT; Ou S; Rich RL; Helmbrecht E; Ko J; Wetzel R; Myszka DG; Patterson PH; Dealwis C
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15659-64. PubMed ID: 17895381
[TBL] [Abstract][Full Text] [Related]
20. Antibody-based therapy in Alzheimer's disease.
Pul R; Dodel R; Stangel M
Expert Opin Biol Ther; 2011 Mar; 11(3):343-57. PubMed ID: 21261567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]